Artificial Intelligence

AIRA MATRIX presents an informative session on optimizing preclinical pathology reporting using AI techniques. The session will familiarize participants with deep learning (DL) modules that help speedup complex workflow processes in...

San Jose, CA, 20th August 2019 -- OptraSCAN®, the leading end-to-end digital pathology solution provider today announced that U.S. Patent and Trademark Office (USPTO) has granted a patent to OptraSCAN’s invention, titled ‘Method of...

SALT LAKE CITY, August 19, 2019—ARUP Laboratories (ARUP), a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI) based image...

Dr. Singh’s extensive experience in medical technologies will help grow the company’s AI-based solutions footprint in pathology labs Tel Aviv, Israel - Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer...

It is an exciting time in the world of digital pathology, with the global market value projected to reach $7,561.1 million by 2022. Currently, industry experts are evaluating the early performance of the first FDA-approved platform. While...

By: Darrell Etherington MIT’s Computer Science and Artificial Intelligence Lab has developed a new deep learning-based AI prediction model that can anticipate the development of breast cancer up to five years in advance. Researchers...